Sweet’s Syndrome Three Weeks after a Severe COVID-19 Infection: A Case Report

Berro, Simar; Calas, Albane; Sohier, Pierre; Darbord, Delphine; Dupin, Nicolas

doi:10.2340/00015555-3850

Cited by 7 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…On the other hand, some authors observed that the dermatologic reactions to mRNA vaccines are often mimickers of those that occurred during SARS-CoV2 infection itself, strengthening the hypothesis that the immune response to the virus is responsible for most of its manifestations [8]. Accordingly, some cases of Sweet's syndrome following SarS-CoV-2 infection have been reported [24,25].…”

Section: Discussionmentioning

confidence: 95%

Sweet Syndrome Following SARS-CoV2 Vaccination

et al. 2021

View full text Add to dashboard Cite

Vaccines are today considered one of the most effective means against the Sars-CoV-2 pandemic. The BNT162b2 vaccine by Pfizer/BioNTech has been massively administered throughout the globe; since its approval, a wide spectrum of cutaneous reactions has been reported. Here we report the case of a 52-year-old Caucasian male who presented with an acute febrile eruption that arose 72 h after the first dose of the BNT162b2 vaccine. The clinicopathological findings were consistent with Sweet’s syndrome. The short latency time suggested a possible role of the vaccine in triggering Sweet’s syndrome in this case.

show abstract

Section: Discussionmentioning

confidence: 95%

Sweet Syndrome Following SARS-CoV2 Vaccination

et al. 2021

View full text Add to dashboard Cite

show abstract

“…45 Of note, both vaccination and SARS-CoV-2 infection may provoke SS. 47 The pathogenesis of neutrophilic diseases still is still not fully understood. In terms of pathogenesis, the available data points to elevated levels of IL-1a, IL-1b, IL-2, IL-6, IL-8, IL-17, TNF-α, and interferon-γ as well as to increased expression of CD3 (T cell marker), CD163 (macrophage marker), vascular endothelial growth factor, Tolllike receptors, C-type lectin innate immunity receptors.…”

Section: Discussionmentioning

confidence: 99%

“…It was accompanied by vasculitis and transient IgA monoclonal gammopathy and occurred 9 days after the administration 45 . Of note, both vaccination and SARS‐CoV‐2 infection may provoke SS 47 …”

Section: Discussionmentioning

confidence: 99%

Atypical presentation of Sweet syndrome with nodular erythema and oral ulcerations provoked by Ad26.COV2.SSARS‐CoV‐2 vaccination and review of literature

Bechtold

Owczarczyk‐Saczonek

2022

Dermatologic Therapy

View full text Add to dashboard Cite

The aim of this article is to present the case of acute febrile neutrophilic dermatosis (Sweet syndrome-SS) after Ad26.COV2.S vaccination against SARS-CoV-2. To the best of our knowledge, this is the second case of SS provoked by this specific vaccine. What is more, the mildly symptomatic beginning of the disease, later followed by typical SS manifestation with a variety of symptoms including nodular erythema of the feet and oral ulcerations, made it very challenging to establish the diagnosis.The article focuses on the current literature on the acute febrile neutrophilic dermatosis, along with the coexistence with other neutrophilic dermatoses and anti-SARS-CoV-2 vaccinations as provoking factors. It emphasizes the necessity for sharing the knowledge and experience on the subject of SS's clinical manifestations and underlying causes to facilitate prompt diagnosis and introduction of appropriate treatment.

show abstract

Neutrophilic Dermatosis and Management Strategies for the Inpatient Dermatologist

et al. 2022

View full text Add to dashboard Cite

Purpose of Review Neutrophilic dermatoses are a heterogeneous group of disorders with significant overlap in associated conditions, clinical presentation, and histopathologic features. This review provides a structural overview of neutrophilic dermatoses that may present in the inpatient setting along with diagnostic work-up and management strategies. Recent Findings Sweet’s syndrome has been found in patients with coronavirus disease 2019 (COVID-19). Pyoderma gangrenosum (PG) has been shown to be equally associated with ulcerative colitis and Crohn’s disease. A clinical trial shows that cyclosporine is equally effective as prednisone in treating PG. Neutrophilic eccrine hidradenitis has been found in the setting of newer antineoplastic medications, such as BRAF inhibitors, as well as in the setting of malignancy without chemotherapy exposure. Summary Neutrophilic dermatoses are a rare and complex group of dermatoses with varying and overlapping clinical presentations. Physicians should be aware of the growing list of associated diseases in order to build a better differential diagnosis or to potentially investigate for co-existing disease.

show abstract

Sweet’s Syndrome Three Weeks after a Severe COVID-19 Infection: A Case Report

Abstract: Fig. 1. Coalescent vesiculo-bullous plaques on (a) the inner left arm, (b) palms and (c) back of the right thigh.

Cited by 7 publications

References 9 publications

Sweet Syndrome Following SARS-CoV2 Vaccination

Sweet Syndrome Following SARS-CoV2 Vaccination

Atypical presentation of Sweet syndrome with nodular erythema and oral ulcerations provoked by Ad26.COV2.SSARS‐CoV‐2 vaccination and review of literature

Neutrophilic Dermatosis and Management Strategies for the Inpatient Dermatologist

Contact Info

Product

Resources

About